Doximity downgraded to Hold from Buy at Canaccord | Nasdaq

3 days ago · Canaccord downgraded Doximity (DOCS) to Hold from Buy with a price target of $60, up from $40. The firm recognizes that Doximity is “currently executing flawlessly,” beating …

CouponFollow Extension

$60
OFF

Doximity Downgraded To Hold From Buy At Canaccord | Nasdaq

1 week from now

3 days ago · Canaccord downgraded Doximity (DOCS) to Hold from Buy with a price target of $60, up from $40. The firm recognizes that Doximity is “currently executing flawlessly,” beating …

nasdaq.com

19%
OFF

Canaccord Genuity Downgrades Doximity (DOCS) - MSN

1 week from now

Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to Hold. Analyst Price Forecast Suggests 28.19% Downside …

msn.com

30%
OFF

Doximity Downgraded At Canaccord After Recent Rally - MSN

1 week from now

Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect …

msn.com

$60
OFF

Canaccord Cautious On Doximity Stock As Robust Growth Already …

1 week from now

4 days ago · On Wednesday, Canaccord Genuity adjusted its stance on Doximity Inc (NYSE: DOCS), downgrading the stock from Buy to Hold while raising the price target to $60 from …

investing.com

30%
OFF

Starbucks, Spotify Downgraded: Wall Street’s Top Analyst Calls

1 week from now

3 days ago · Canaccord downgraded Doximity to Hold from Buy with a price target of $60, up from $40. The firm recognizes that Doximity is “currently executing flawlessly,” but with the 30% …

nasdaq.com

$60
OFF

Morgan Stanley Upgrades Doximity Stock But Warns Of Stretched …

1 week from now

3 days ago · In the wake of these strong results, Canaccord Genuity adjusted its stance on Doximity, downgrading the stock from Buy to Hold while raising the price target to $60 from $40.

investing.com

$30
OFF

Canaccord Genuity Downgrades Doximity To Hold From Buy, …

1 week from now

-- Doximity has an average rating of outperform and price targets ranging from $30 to $75, according to analysts polled by Capital IQ. Price: 56.55, Change: -1.50, Percent Change: -2.58 ...

marketscreener.com

$60.00
OFF

Canaccord Genuity Downgrades Doximity Inc (DOCS) To Hold

1 week from now

4 days ago · Canaccord Genuity analyst Richard Close downgraded Doximity Inc (NYSE: DOCS) from Buy to Hold with a price target of $60.00 (from $40.00).The analyst comments: "We are …

streetinsider.com

$40
OFF

Canaccord Genuity Downgrades Doximity To Hold, Raises Price …

1 week from now

4 days ago · Canaccord Genuity analyst Richard Close downgrades Doximity (NYSE:DOCS) from Buy to Hold and raises the price target from $40 to $60.

sahmcapital.com

$49
OFF

Doximity Price Target Raised To $49 From $35 At Truist - Nasdaq

1 week from now

2 days ago · Doximity downgraded to Hold from Buy at Canaccord Doximity price target raised to $75 from $52 at Barclays Nvidia trades on Dow for first time, Rivian reports downbeat Q3: …

nasdaq.com

$75
OFF

Doximity Upgraded To Equal Weight From Underweight At Morgan …

1 week from now

2 days ago · Doximity downgraded to Hold from Buy at Canaccord; Doximity price target raised to $75 from $52 at Barclays; Nvidia trades on Dow for first time, Rivian reports downbeat Q3: …

nasdaq.com

$2
OFF

Plug Power Price Target Lowered To $2 From $2.25 At Canaccord

1 week from now

1 day ago · Canaccord lowered the firm’s price target on Plug Power (PLUG) to $2 from $2.25 and keeps a Hold rating on the shares. The firm said 2024 has been filled with challenges, …

nasdaq.com

$17
OFF

Progyny Price Target Lowered To $17 From $18 At Canaccord

1 week from now

3 days ago · Canaccord analyst Richard Close lowered the firm’s price target on Progyny (PGNY) to $17 from $18 and keeps a Hold rating on the shares. The firm lowered its estimates after …

nasdaq.com

FAQs about Doximity downgraded to Hold from Buy at Canaccord | Nasdaq Coupon?

Is Doximity (Docs) a good stock to buy in 2024?

Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to Hold. Analyst Price Forecast Suggests 28.19% Downside As of October 22, 2024, the average one-year price target for Doximity is $37.96/share. The forecasts range from a low of $19.19 to a high of $54.60. ...

Should you buy Doximity (Docs)?

Play(1min) ozgurdonmaz/E+ via Getty Images Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect high expectations for the online medical platform. ...

Is Doximity a good investment?

According to analysts, Doximity has a consensus rating of Hold with an average rating score of 2.00 based on 2 buy ratings, 10 hold ratings, and 2 sell ratings. The forecasted upside from its current price of $25.87 is 11.4%, as per the consensus price target of $28.82. ...

Why did Genuity downgrade Doximity (Docs)?

C anaccord Genuity on Wednesday downgraded Doximity (NYSE: DOCS) to hold from buy, noting that its shares, after a more than 30% rally following the company’s Q2 results, already reflect high expectations for the online medical platform. ...

Should you buy Seeking Alpha Doximity (Docs) stock?

Do Not Sell My Personal Information Market Data Sources © 2024 Seeking Alpha Doximity (DOCS) stock falls as Canaccord Genuity downgrades it to hold from buy, on high expectations reflected in its shares after earnings-led rally. Read more here. ...

Does Doximity (Docs) have a good Q2 performance?

Acknowledging Doximity’s (DOCS) Q2 beat and better-than-expected guidance, Canaccord notes that the company is delivering record-adjusted EBITDA margins and generating strong free cash flow. ...